Search
Search Results
- Publication:
- Silver Spring, MD : Center for Drug Evaluation and Research, October 2020
- Subject(s):
- Analgesics, Opioid
Opioid-Related Disorders -- drug therapy
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.
- Publication:
- Washington, DC : United States Government Accountability Office, January 2020
- Subject(s):
- Analgesics, Opioid -- supply & distribution
Analgesics, Opioid -- therapeutic use
Health Services Accessibility
Medicaid -- economics
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
United States
Centers for Medicare & Medicaid Services (U.S.)
- Publication:
- [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, January 2020
- Subject(s):
- Buprenorphine -- supply & distribution
Health Services Accessibility
Medically Underserved Area
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
United States
United States. Department of Health and Human Services
United States. Substance Abuse and Mental Health Services Administration
- Author(s):
- Aronowitz, Shoshana V., author
Behrends, Czarina Navos, author
Lowenstein, Margaret, author
Schackman, Bruce, author
Weiner, Janet, author
- Publication:
- Philadelphia, PA : Leonard Davis Institute of Health Economics, January 2022
- Subject(s):
- Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Health Services Accessibility
United States
- Author(s):
- Au-Yeung, Caroline M., author
Blewett, Lynn A., author
Winkelman, Tyler N.A., author
- Publication:
- New York, NY : Milbank Memorial Fund, October 2021
- Subject(s):
- Health Services Accessibility
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Buprenorphine -- therapeutic use
COVID-19
Health Policy
Methadone -- therapeutic use
Naltrexone -- therapeutic use
United States
- Publication:
- Silver Spring, MD : Center for Drug Evaluation and Research, February 2019
- Subject(s):
- Buprenorphine -- therapeutic use
Drug Development
Opioid-Related Disorders -- drug therapy
Buprenorphine -- administration & dosage
Clinical Trials as Topic
Delayed-Action Preparations
Narcotic Antagonists
Opiate Substitution Treatment
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.
- Publication:
- [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, July 2019
- Subject(s):
- Analgesics, Opioid -- therapeutic use
Medicare Part D
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Drug Overdose -- drug therapy
Drug Utilization -- trends
Forecasting
Inappropriate Prescribing
Naloxone -- therapeutic use
State Government
Humans
United States
- Author(s):
- Newman, Sandra, author
- Publication:
- [Oakland, California] : California Health Care Foundation, March 2019
- Subject(s):
- Emergency Medical Services
Emergency Service, Hospital
Insurance, Health, Reimbursement
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Substance-Related Disorders -- drug therapy
Buprenorphine -- therapeutic use
Inservice Training
Methadone -- therapeutic use
State Government
Telemedicine
Humans
California
United States
- Author(s):
- Newman, Sandra, author
- Publication:
- [Oakland, California] : California Health Care Foundation, June 2019
- Subject(s):
- Hospitalization
Inpatients
Insurance, Health, Reimbursement
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Buprenorphine -- therapeutic use
Drug Costs
Hospital Costs
Methadone -- therapeutic use
Reimbursement Mechanisms
State Government
Humans
California
United States
- Publication:
- [Oakland, California] : California Health Care Foundation, June 2019
- Subject(s):
- Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Telemedicine
Insurance, Health, Reimbursement
Mental Health Services
Opioid Epidemic
State Government
Humans
California
United States
